يعرض 141 - 160 نتائج من 15,205 نتيجة بحث عن '(( significantly ((less decrease) OR (we decrease)) ) OR ( significantly increased decrease ))', وقت الاستعلام: 0.43s تنقيح النتائج
  1. 141

    S3 Table - حسب Yong-Rae Kim (19797278)

    منشور في 2024
    الموضوعات:
  2. 142

    S5 Table - حسب Yong-Rae Kim (19797278)

    منشور في 2024
    الموضوعات:
  3. 143

    S1 Table - حسب Yong-Rae Kim (19797278)

    منشور في 2024
    الموضوعات:
  4. 144

    S2 Table - حسب Yong-Rae Kim (19797278)

    منشور في 2024
    الموضوعات:
  5. 145
  6. 146

    S4 Table - حسب Yong-Rae Kim (19797278)

    منشور في 2024
    الموضوعات:
  7. 147

    S6 Table - حسب Yong-Rae Kim (19797278)

    منشور في 2024
    الموضوعات:
  8. 148
  9. 149
  10. 150

    Data from: <b>Selection and genetic variation in plasticity drive age-related decreases in among-individual behavioural correlations</b> حسب Chang Seok Han (21814121)

    منشور في 2025
    "…Our findings indicate that the magnitudes of both the positive among-individual and genetic correlations were maintained across nymph and young adult stages, but significantly decreased with age during adulthood. This decrease was due to both selection and genetic variation in age-related behavioural plasticity. …"
  11. 151
  12. 152
  13. 153
  14. 154
  15. 155
  16. 156
  17. 157

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  18. 158

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  19. 159

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  20. 160